- Home
- MNOV vs NCSM Comparison
MNOV vs NCSM Comparison
Compare MNOV & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNOV
- NCSM
- Stock Information
- Founded
- MNOV 2000
- NCSM 2006
- Country
- MNOV United States
- NCSM United States
- Employees
- MNOV N/A
- NCSM N/A
- Industry
- MNOV Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- MNOV Health Care
- NCSM Energy
- Exchange
- MNOV Nasdaq
- NCSM Nasdaq
- Market Cap
- MNOV 68.2M
- NCSM 76.3M
- IPO Year
- MNOV 2005
- NCSM 2017
- Fundamental
- Price
- MNOV $1.35
- NCSM $30.04
- Analyst Decision
- MNOV Strong Buy
- NCSM
- Analyst Count
- MNOV 2
- NCSM 0
- Target Price
- MNOV $7.00
- NCSM N/A
- AVG Volume (30 Days)
- MNOV 48.4K
- NCSM 3.6K
- Earning Date
- MNOV 08-07-2025
- NCSM 07-31-2025
- Dividend Yield
- MNOV N/A
- NCSM N/A
- EPS Growth
- MNOV N/A
- NCSM N/A
- EPS
- MNOV N/A
- NCSM 3.27
- Revenue
- MNOV N/A
- NCSM $168,704,000.00
- Revenue This Year
- MNOV N/A
- NCSM $7.17
- Revenue Next Year
- MNOV N/A
- NCSM $5.44
- P/E Ratio
- MNOV N/A
- NCSM $9.38
- Revenue Growth
- MNOV N/A
- NCSM 18.16
- 52 Week Low
- MNOV $1.12
- NCSM $16.66
- 52 Week High
- MNOV $2.55
- NCSM $38.95
- Technical
- Relative Strength Index (RSI)
- MNOV 54.24
- NCSM 47.19
- Support Level
- MNOV $1.31
- NCSM $30.09
- Resistance Level
- MNOV $1.50
- NCSM $30.85
- Average True Range (ATR)
- MNOV 0.06
- NCSM 0.64
- MACD
- MNOV 0.02
- NCSM 0.01
- Stochastic Oscillator
- MNOV 48.28
- NCSM 28.70
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.